PORCELLI, LETIZIA
 Distribuzione geografica
Continente #
NA - Nord America 2.000
AS - Asia 777
EU - Europa 565
SA - Sud America 244
AF - Africa 53
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 2
Totale 3.645
Nazione #
US - Stati Uniti d'America 1.959
SG - Singapore 305
BR - Brasile 201
CN - Cina 151
RU - Federazione Russa 120
SE - Svezia 110
HK - Hong Kong 92
IT - Italia 88
VN - Vietnam 72
DE - Germania 61
GB - Regno Unito 46
FR - Francia 45
FI - Finlandia 28
CA - Canada 26
IN - India 26
CI - Costa d'Avorio 24
BE - Belgio 21
ID - Indonesia 17
AR - Argentina 15
TR - Turchia 15
IQ - Iraq 14
BD - Bangladesh 12
JP - Giappone 12
AT - Austria 10
ZA - Sudafrica 9
CO - Colombia 8
UZ - Uzbekistan 8
NL - Olanda 7
VE - Venezuela 7
LT - Lituania 6
MX - Messico 6
PK - Pakistan 6
PL - Polonia 6
TN - Tunisia 6
EC - Ecuador 5
PH - Filippine 5
AE - Emirati Arabi Uniti 4
KR - Corea 4
MA - Marocco 4
NP - Nepal 4
PY - Paraguay 4
AU - Australia 3
AZ - Azerbaigian 3
BO - Bolivia 3
ES - Italia 3
JO - Giordania 3
MY - Malesia 3
SA - Arabia Saudita 3
AL - Albania 2
BH - Bahrain 2
CZ - Repubblica Ceca 2
HN - Honduras 2
IL - Israele 2
JM - Giamaica 2
KE - Kenya 2
KW - Kuwait 2
KZ - Kazakistan 2
MV - Maldive 2
TT - Trinidad e Tobago 2
AM - Armenia 1
AO - Angola 1
BG - Bulgaria 1
CH - Svizzera 1
CL - Cile 1
CV - Capo Verde 1
CW - ???statistics.table.value.countryCode.CW??? 1
DZ - Algeria 1
EG - Egitto 1
ET - Etiopia 1
GA - Gabon 1
GD - Grenada 1
GE - Georgia 1
GR - Grecia 1
GT - Guatemala 1
IE - Irlanda 1
IR - Iran 1
KG - Kirghizistan 1
LB - Libano 1
LC - Santa Lucia 1
LY - Libia 1
MD - Moldavia 1
MT - Malta 1
NR - Nauru 1
PS - Palestinian Territory 1
PT - Portogallo 1
RO - Romania 1
RS - Serbia 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
UA - Ucraina 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 3.645
Città #
Ashburn 250
Fairfield 221
Singapore 168
Woodbridge 167
Chandler 154
San Jose 114
Houston 94
Hong Kong 92
Seattle 92
Cambridge 87
Nyköping 83
Wilmington 67
Beijing 61
Ann Arbor 49
New York 42
Bari 37
Los Angeles 28
Ho Chi Minh City 27
Abidjan 24
Lawrence 24
Brooklyn 23
Dallas 23
Munich 23
Roxbury 23
Lauterbourg 22
Brussels 21
Council Bluffs 20
São Paulo 20
Hanoi 15
Santa Clara 15
Moscow 14
Helsinki 13
The Dalles 13
Columbus 12
Des Moines 12
Jakarta 12
London 12
Nanjing 12
Tokyo 12
Paris 11
San Diego 10
Baghdad 9
Dearborn 9
Turku 9
Falkenstein 8
Montreal 7
Orem 7
Tashkent 7
Vienna 7
Boardman 6
Brasília 6
Dong Ket 6
Inglewood 6
Miami 6
Monmouth Junction 6
San Francisco 6
Warsaw 6
Amsterdam 5
Ankara 5
Buffalo 5
Chennai 5
Chicago 5
Denver 5
Frankfurt am Main 5
Poplar 5
Porto Alegre 5
Shanghai 5
Toronto 5
Atlanta 4
Belo Horizonte 4
Calgary 4
Chandigarh 4
Charlotte 4
Detroit 4
Falls Church 4
Johannesburg 4
Marseille 4
Nanchang 4
Napoli 4
North Bergen 4
Ottawa 4
Phoenix 4
Pune 4
Rio de Janeiro 4
Washington 4
Amman 3
Baku 3
Barranquilla 3
Changsha 3
Curitiba 3
Dhaka 3
Goiânia 3
Haiphong 3
Hortolândia 3
Jiaxing 3
Joinville 3
Kunming 3
Leawood 3
Maringá 3
Nuremberg 3
Totale 2.498
Nome #
New insight into the role of metabolic reprogramming in melanoma cells harboring braf mutations. 219
Sorafenib delivery nanoplatform based on superparamagnetic iron oxide nanoparticles magnetically targets hepatocellular carcinoma 190
Drug delivery nanovectors based on SPIONS for targeted therapy of hepatocellular carcinoma 179
Gene Expression Comparison between the Lymph Node-Positive and -Negative Reveals a Peculiar Immune Microenvironment Signature and a Theranostic Role for WNT Targeting in Pancreatic Ductal Adenocarcinoma: A Pilot Study 179
Detrimental effects of melanocortin-1 receptor (MC1R) variants on the clinical outcomes of BRAF V600 metastatic melanoma patients treated with BRAF inhibitors 175
CAFs and TGF-β Signaling Activation by Mast Cells Contribute to Resistance to Gemcitabine/Nabpaclitaxel in Pancreatic Cancer 175
Small P-gp modulating molecules: SAR studies on tetrahydroisoquinoline derivatives 162
EGFR tyrosine kinases inhibitors in cancer treatment: in vitro and in vivo evidence 155
Anti-EGFR monoclonal antibody in cancer treatment: In vitro and in vivo evidence 153
Targeting human liver cancer cells with lactobionic acid-G(4)-PAMAM-FITC sorafenib loaded dendrimers 149
Potential predictive role of chemotherapy-induced changes of soluble CD40 ligand in untreated advanced pancreatic ductal adenocarcinoma 147
The coordinated role of CYP450 enzymes and P-gp in determining cancer resistance to chemotherapy 140
Optimize radiochemotherapy in pancreatic cancer: PARP inhibitors a new therapeutic opportunity 137
Synthetic lethality to overcome cancer drug resistance 135
p53 as the main traffic controller of the cell signaling network 130
Hydroxy-propil-β-cyclodextrin inclusion complexes of two biphenylnicotinamide derivatives: Formulation and anti-proliferative activity evaluation in pancreatic cancer cell models 114
Cyclohexylpiperazine derivative PB28, a σ2 agonist and σ1 antagonist receptor, inhibits cell growth, modulates P-glycoprotein, and synergizes with anthracyclines in breast cancer 106
Hepatic stellate cells induce hepatocellular carcinoma cell resistance to sorafenib through the laminin-332/α3 integrin axis recovery of focal adhesion kinase ubiquitination 104
Tomatine displays antitumor potential in in vitro models of metastatic melanoma 100
The β-adrenergic receptor antagonist propranolol offsets resistance mechanisms to chemotherapeutics in diverse sarcoma subtypes: a pilot study 97
BRAFV600E;K601Q metastatic melanoma patient-derived organoids and docking analysis to predict the response to targeted therapy 93
Long non‐coding rna landscape in prostate cancer molecular subtypes: A feature selection approach 92
null 86
Synergistic antiproliferative and antiangiogenic effects of EGFR and mTOR inhibitors 84
Gene Expression Comparison between Alcohol-Exposed Versus Not Exposed Pancreatic Ductal Adenocarcinoma Patients Reveals a Peculiar TGFβ-Related Phenotype: An Exploratory Analysis 83
The role of non-coding RNAs as prognostic factor, predictor of drug response or resistance and pharmacological targets, in the cutaneous squamous cell carcinoma 76
IRISIN AND METASTATIC MELANOMA: SELECTIVE ANTI-INVASIVENESS ACTIVITY IN BRAF WILD-TYPE CELLS 72
Probing the interaction between cisplatin and the therapeutic monoclonal antibody trastuzumab 71
null 71
Circulating extracellular vesicles are monitoring biomarkers of anti-PD1 response and enhancer of tumor progression and immunosuppression in metastatic melanoma 70
Cervical cancer benefits from trabectedin combination with the β-blocker propranolol: in vitro and ex vivo evaluations in patient-derived organoids 41
Totale 3.785
Categoria #
all - tutte 15.081
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.081


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021112 0 0 0 0 0 0 0 0 0 48 44 20
2021/2022262 9 31 3 3 21 30 10 15 20 22 29 69
2022/2023393 38 66 26 41 31 51 10 41 64 3 9 13
2023/2024149 16 19 14 11 23 42 2 8 4 3 0 7
2024/2025703 30 13 31 41 40 53 138 80 33 25 71 148
2025/20261.219 218 69 96 140 181 70 107 39 179 120 0 0
Totale 3.785